MICROSINTESIS
MicroSintesis is a new life sciences company focused on creating novel anti-infectives. MicroSintesis has developed a unique technology that uses natural bioactive molecules produced by probiotics to reduce significantly the expression of the virulence genes of multiple pathogenic bacteria. The result is a new way to reduce antibiotic use and create a first line of defense in the fight against antibiotic resistance bacteria.
MICROSINTESIS
Social Links:
Industry:
Biotechnology
Founded:
2011-01-01
Address:
Charlottetown, Prince Edward Island, Canada
Country:
Canada
Website Url:
http://www.microsintesis.com
Total Employee:
11+
Status:
Active
Contact:
1-844-442-1110
Email Addresses:
[email protected]
Total Funding:
16.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics WordPress Google Universal Analytics Font Awesome Wordpress Plugins Nginx
Similar Organizations
Arix Bioscience
Arix Bioscience is a global venture capital company that invests in breakthrough biotechnology companies.
Cygnal Therapeutics
Cygnal Therapeutics is a biotechnology company
Faze Medicines
Faze Medicines is a biotechnology company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Northern Private Capital (NPC)
Northern Private Capital (NPC) investment in Venture Round - MicroSintesis
Official Site Inspections
http://www.microsintesis.com
- Host name: 576454-db1.digitalchaos.ca
- IP address: 162.242.201.56
- Location: San Antonio United States
- Latitude: 29.4963
- Longitude: -98.4004
- Metro Code: 641
- Timezone: America/Chicago
- Postal: 78218
More informations about "MicroSintesis"
MicroSintesis – A life sciences company pioneering gut health in ...
Microsintesis is an animal health company. We're pioneering animal gut health through proteobiotics, a next-generation probiotic technology for pigs and dogs.See details»
About – MicroSintesis
Microsintesis is an animal health company. We're pioneering animal gut health through proteobiotics, a next-generation probiotic technology for pigs and dogs.See details»
MicroSintesis - Crunchbase Company Profile & Funding
MicroSintesis is a new life sciences company focused on creating novel anti-infectives. MicroSintesis has developed a unique technology that uses natural bioactive molecules produced by probiotics to reduce significantly the …See details»
MicroSintesis Inc. - LinkedIn
We are committed to lead microbiome's research, discover proven & effective alternative to antibiotics, impact long standing health challenges, improve human and animal welfare and …See details»
Contact – MicroSintesis
Microsintesis is an animal health company. We're pioneering animal gut health through proteobiotics, a next-generation probiotic technology for pigs and dogs.See details»
MicroSintesis Closes $16.4M Round - entrevestor.com
Jun 25, 2019 · Charlottetown-based MicroSintesis, which has developed a revolutionary product to ensure gut health in animals, has sold a minority stake to John Risley’s Northern Private Capital for $16.4 million. MicroSintesis is …See details»
MicroSintesis Inc. | BIOSCIENCE - Profile | Greater Charlottetown …
MicroSintesis is a Canadian biotech company that is harnessing the power of the microbiome’s natural defense system (Quorum quenching) to create a new category of products targeting …See details»
P.E.I. bio-science firm eyes expansion to global markets …
Jul 3, 2019 · MicroSintesis has closed a deal worth $16.4 million with Toronto-based Northern Private Capital. "The world is focused on antibiotic resistance ... so we're looking to take our technology to...See details»
Microsintesis, Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Microsintesis, Inc of Victoria, PE. Get the latest business insights from Dun & Bradstreet.See details»
Hannah McIver - CEO at MicroSintesis - The Org
With MicroSintesis, Hannah’s strong sense of mission (the Toronto Star calls her a “serial entrepreneur”) is now focused on making MicroSintesis a leader in the science of proteobiotics.See details»
MicroSintesis Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for MicroSintesis. Use the PitchBook Platform to explore the full profile.See details»
MicroSintesis – NPC - Fringe Media
MicroSintesis has developed a suite of natural, probiotic-based health products used in place of antibiotics and other conventional drugs for both livestock and companion animals.See details»
MicroSintesis - NPC
MicroSintesis has developed a suite of natural, probiotic-based health products used in place of antibiotics and other conventional drugs for both livestock and companion animals.See details»
Alain Labbe - Research Director - MicroSintesis Inc. - LinkedIn
In March 2020, I joined MicroSintesis as Research Director. · Experience: MicroSintesis Inc. · Location: Saint-Philippe · 153 connections on LinkedIn. View Alain Labbe’s profile on …See details»
MicroSintesis Company Profile - Office Locations, Competitors
Microsintesis is an animal health company providing proteobiotics for gut health. The company focuses on creating anti-infectives. MicroSintesis has 5 employees at their 1 location and …See details»
MicroSintesis announces $16.4M investment – PEI BioAlliance
Jun 28, 2019 · Hannah McIver, Chief Executive Officer and Founder of Charlottetown-based MicroSintesis, announced Wednesday that her company has received a $16.4-million minority …See details»
New First Line of Defense against Antibiotic-Resistant ... - Newswire
Nov 26, 2015 · /CNW/ - MicroSintesis Inc., a new life sciences company focused on creating novel anti-infectives, has successfully completed its largest study to date on the...See details»
MicroSintesis lands US$12.4M investment to scale up microbiome …
26 Jun 2019 --- Proprietary microbiome therapies company MicroSintesis has closed a minority investment deal worth Can$16.4 million (US$12.4 million) with Northern Private Capital (NPC), …See details»
MicroSintesis - PEI BioAlliance
Mar 12, 2018 · MicroSintesis is a new life sciences company focused on creating novel anti-infectives. By harnessing the natural defense mechanisms of probiotics, MicroSintesis is on …See details»
MicroSintesis | VentureRadar
Similar Companies: Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, …See details»